Knee replacement Market 2021- Top Trends And Detailed Analysis, Demand, Research Report, Growth to forecast till 2025

 The global knee replacement market is expected to exhibit a 3.7% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global knee replacement market is expected to reach USD 10 billion by 2025, according to the report. The global knee replacement market is profiled in great detail in the research report, providing readers with a comprehensive overview of the market through its historical growth trajectory, present conditions, and future growth prospects. 

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1578   

The historical stats of the knee replacement market are detailed in the report, in order to provide readers with a complete overview of the market’s historical growth trajectory. The historical stats provided in the report also give analysts a solid platform to base future projections about the market. Based on this platform, future projections for the knee replacement market’s growth trajectory over the forecast period are provided in the report. The leading players in the global knee replacement market are also profiled in the report in order to give readers a comprehensive analysis of the leading players in the global knee replacement market. The major drivers and restraints affecting the global knee replacement market are also profiled in the report to provide readers a comprehensive overview of what’s making the market tick and what is holding the market back.

Knee replacement, also known as knee arthroplasty, is a joint replacement procedure performed to replace diseased knee joints with functional alternatives made from materials such as metals and ceramics. Knee replacement is often performed on patients suffering from rheumatic arthritis, post-traumatic arthritis, or osteoarthritis. The growing awareness about knee replacement procedures is likely to be a major driver for the knee replacement market over the forecast period. In recent years, many advancements have been made in the field of knee replacement, with advanced composite materials often replacing the older metal implants and noninvasive surgical procedures replacing the older, invasive procedures. This has been a major driver for the global knee replacement market. 

The increasing geriatric population around the world is likely to be a major driver for the global knee replacement market over the forecast period. Geriatrics are the most likely to require knee transplants, due to age-related damage to the knees and the onset of arthritis with age. The increasing lifestyle standards around the world have led to an increase in the population of geriatrics. This is likely to remain the major driver for the global knee replacement market over the forecast period. 

Competitive Leaderboard:

Leading players in the global knee replacement market include Kinamed Inc., Allegra Orthopaedics Ltd., Medacta International, Aesculap Implants Systems LLC, Corin Group, Exactech Inc., Smith and Nephew, Stryker, DePuy Synthes, and Zimmer Inc. 

Segmentation:

The global knee replacement market is segmented on the basis of product type, material type, end user, and region. 

By product type, the global knee replacement market is segmented into partial knee reconstructive implants, total knee reconstructive implants, and revision knee reconstructive implants. The total knee reconstructive implants segment is further subcategorized into medial pivot implants, mobile bearing implants, fixed bearing implants, and others. 

By material type, the global knee replacement market is segmented into ceramics, metal alloys, strong plastic parts, and others. 

By end use, the global knee replacement market is segmented into hospitals and clinics, specialty centers, and rehabilitation centers. The hospitals and clinics segment holds the largest share in the global knee replacement market. 

Regional Analysis:

Geographically, the global knee replacement market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. 

The Americas hold the largest share in the global knee replacement market. The high population of geriatrics in the region is the prime driver for the knee replacement market in the region. The increasing prevalence of lifestyle disorders such as diabetes is also likely to be a major driver for the knee replacement market in the Americas region. 

Browse Complete Report with Toc @ https://www.marketresearchfuture.com/reports/knee-replacement-market-1578 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Biosimilars Market Growth Drivers, Trends, Business Opportunities, Competitive Landscape, Strategies, Developments and Impact of COVID-19

 Biosimilars Market-Highlights

The global biosimilars market is expected to exhibit a strong 7.5% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global biosimilars market was valued at USD 13.4 billion in 2018. 

Get Free Sample Copy Of Biosimilars Market @ https://www.marketresearchfuture.com/sample_request/1329 

Biosimilars are biological medicines that are highly similar to another already approved medicine. The patent expiry of several blockbuster drugs has been a major driver for the global biosimilars market over the last few years, as this has driven the demand for generics and other alternatives to blockbuster drugs. This is likely to remain a major driver for the global biosimilars market over the forecast period, with several blockbuster drugs expected to lose their patents in the coming years, leading to a growing demand for alternatives. Due to the high profitability of biosimilars, many pharmaceutical companies have invested significantly in the development of biosimilars in the last few years. Biosimilars have become a highly useful and lucrative addition to the portfolio of pharmaceutical giants in the last few years. This is also likely to remain a key driver for the global biosimilars market over the forecast period. 

The growing prevalence of chronic diseases is also likely to be a major driver for the global biosimilars market over the forecast period. The increasing prevalence of orthopedic, hematological, oncological, and neurological diseases that take a long time to fix has been a boon for the biosimilars market, as this has driven the demand for effective biological drugs to treat the diseases. The increasing demand from patients for biological products, which are viewed as being healthier and more effective than synthetic products, is also likely to be a major driver for the global biosimilars market over the forecast period. Noting the growing demand for biosimilars, the U.S. FDA has approved numerous biosimilars drugs over the last few years. This has also been a major driver for the global biosimilars market and is likely to remain a key driver for the market over the forecast period. 

Biosimilars Market Competitive Leaderboard:

Leading players in the global biosimilars market include Mylan Inc., Stada Arzneimittel AG, Cipla Ltd., Actavis Inc., Hospira Inc., Eli Lily and Company, Samsung Biologics, Celltrion, Dr. Reddy’s Laboratories, Biocon, Amgen Inc., Teva Pharmaceuticals, Sandoz International, and Pfizer. Major players in the global biosimilars market are likely to focus on product expansion and development over the forecast period. Developing new, varied biosimilars for multiple diseases is likely to remain a profitable venture for players in the biosimilars market over the forecast period. 

Biosimilars Market Segmentation:

The global biosimilars market is segmented on the basis of product, application, end user, and region. 

By product type, the global biosimilars market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins are further divided into human growth hormone (RHGH), granulocyte colony-stimulating factor (filgrastim), insulin, and interferons. Similarly, the recombinant glycosylated proteins segment is further sub-segmented into erythropoietin (EPO), monoclonal antibodies (MABS), and follitropin. The recombinant peptides segment has been subdivided into glucagon and calcitonin. The recombinant non-glycosylated proteins segment is expected to hold a major share in the market due to an increase in the incidence of chronic diseases, diabetes, and growth hormone deficiency-related disorders. Thus, the therapeutic use of recombinant non-glycosylated proteins is broadening.  

By application, the global biosimilars market is segmented into oncology, chronic diseases, autoimmune diseases, blood disorders, growth hormone deficiency, infectious diseases, and others. The blood disorders segment is expected to exhibit growth at a high growth rate over the forecast period due to the growing realization of the usability of biosimilars in treating blood disorders. 

By end use, the global biosimilars market is segmented into hospitals and clinics, research institutes, and others. Hospitals and clinics are likely to hold the largest share in the global biosimilars market over the forecast period. 

Biosimilars Market Regional Analysis:

Europe is expected to dominate the global biosimilars market over the forecast period, followed by North America. Increasing product launches and supportive schemes from governments in the region are the major driver for the Europe and North America biosimilars markets. 

OBTAIN RESEARCH REPORT DETAILS WITH TOC @

https://www.marketresearchfuture.com/reports/biosimilars-market-1329

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Clinical Nutrition Market Demand Forecast, Growth Analysis, Industry Size, Share, Investment Opportunities, Business Revenue, Company Profiles and Impact of COVID-19

 Clinical nutrition is targeted at patients ranging from infancy to old age and assisting them with their dietary habits. It covers dietary information for patients with chronic conditions, grievous injuries, and counseling for healthier lifestyles. The global clinical nutrition market report covers the latest trends and opportunities for the period of 2017 to 2027 (forecast period). The impact of the COVID-19 pandemic has been taken into consideration for estimating the scope of the market.

Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/829 

Market Scope

The global clinical nutrition market is expected to attain an overwhelming demand over the forecast period owing to the rise in health consciousness among the populace. Awareness of chronic diseases, rising number of cases, and a large geriatric populace are other drivers of the market. The loss of appetite in the elderly and low intake of necessary foods can trigger the need for clinical nutrition. Their susceptibility to diseases can favor the market even further.

The large cases of malnourishment are also touted to drive the market growth. As per a 2017 report by WHO, there are close to 15 million premature births globally. The impact of the COVID-19 pandemic on the industry is huge owing to vital supplements and medicines being in short supply due to lockdowns imposed in nations. Rising number of cases of obesity and diabetes is one of the prime factors fueling market growth prospects.

But strict regulations pertaining to approval can hamper market growth.

Segmentation

The global clinical nutrition market is segmented by product. By product, it is segmented into parenteral nutrition, enteral nutrition, and infant nutrition. Infant nutrition is expected to gain a major share of the market till the end of the forecast period. The cases of malnourished children in developing economies are an indicator of the large potential of the market. Awareness programs aimed at educating the masses can foster the growth of the segment as well. 

Enteral nutrition is further divided into standard and chronic illness, while parenteral nutrition is segmented into probiotic/prebiotic, soy based, milk based, organic, and others. Within the parenteral nutrition segment, the milk-based segment is expected to fetch huge revenues for the market.

Regional Analysis

North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions covered in the global clinical nutrition market.

APAC is expected to dominate the market owing to number of premature births and rising awareness of clinical products. The large disposable income levels of consumers, the growing workforce of women, and urbanization can fuel the regional clinical nutrition market. Presence of nutritionists and dieticians and a large populace of the elderly can bode well for the market.

North America accounted for 23.1% market share in 2017. Large healthcare burden and awareness of clinical nutrition in the U.S. can augur favorably for the market. The high birth rate and sales of infant formulas are evidence of the large potential of the market. In addition, the manufacture of suitable products by nutritional manufacturers, food programs, and focus on elderly care can be lucrative avenues for the market to expand.

Competition Outlook

Fresenius Kabi AG, GroupeDanone, B. Braun Melsungen AG, Abbott Laboratories, Perrigo Company Plc, Hospira, Inc, Baxter International, Inc, Nestlé S.A, and Mead Johnson Nutrition Company are key players of the global clinical nutrition market.

Related reports:

https://www.medgadget.com/2020/08/global-diagnostic-electrocardiograph-ecg-market-2020-size-industry-share-technology-trends-key-values-demand-by-product-type-lead-type-end-user-and-region.html

https://www.medgadget.com/2020/08/advances-research-on-bioanalytical-testing-services-market-size-share-investment-growth-factors-key-values-demand-global-analysis-and-forecast.html

https://www.medgadget.com/2020/09/surgical-retractors-market-outlook-2020-industry-trends-comprehensive-analysis-growth-factors-application-design-segmentation-regional-analysis-prominent-players-and-forecast.html

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Gene Editing Market Driving Factors, Industry Analysis, Investment Feasibility and Trends, Outlook -2023

 Gene editing, genome editing, or genome engineering is a type of genetic engineering in which the gene of a particular organism is modified, added, or deleted for treatment of particular diseases. Early methods of gene editing have led to the insertion of the genome sequence within the cell such as homologous recombination. The global gene editing market report compiled by Market Research Future (MRFR) takes a look at various methods and its future potential for the period of 2018 to 2023 (forecast period).

Free Sample Copy With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/707 

Market Scope

The global gene editing market is predicted to expand at 18.30% CAGR during the forecast period. It can thrive by modifying the DNA of livestock to increase their immunity or defenses against certain bacteria. Gene-editing therapies on animals and their approval from regulatory bodies can bode well for the market. Furthermore, prevalence of cancer, hemophilia, HIV, and sickle cell anemia will drive the demand in the global market.

Applications in pet breeding, allergy-free foods, biodiesel, and others can drive the technological usage of CRISPR-Cas9. The use of gene editing techniques to remove mutations in DNA of companion animals and improve their overall health will be lucrative for manufacturers in the coming years. Prevalence of lactose intolerance and celiac disease is bound to spur the need for such technologies and drive the production of allergen-free foods.

Strict regulations pertaining to the technology and adverse public perception may restrain the global gene editing market growth. 

Segmentation

The global gene editing market is segmented on basis of methods, applications, and end users. 

Based on methods, the market is segmented as Antisense technology, ZFN, CRISPR, TALEN, and others.

On the basis of application they are segmented as gene therapy, plant genetic engineering, animal genetic engineering, and microorganism’s genetic engineering. 

On the basis of end users, the market is segmented into contract research organizations, biotechnology, and pharmaceuticals.    

Regional Analysis

On the regional basis, the market is segmented into Americas, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).

The Americas are predicted to dominate the market owing to developments in drug discovery, investments in drugs and vaccines, rise in research studies, and mushrooming of the biotechnology sector. The increase in research expenditure, incidence of chronic diseases, and use of stem cells are major drivers of the market. The U.S., in particular, will drive the market growth till 2023. Sale of do-it-yourself (DIY) genetic engineering kits can lead to research at home and create interest among budding scientists. However, the ban on the sale of such kits may hamper its growth.

APAC, on the other hand, is likely to display the fastest growth rate during the forecast period owing to funds invested in public research organizations to further research in biotechnology. Establishment of gene editing companies and increased spending on research and development can fuel the market growth. Production of generic drugs and presence of contract research organizations will bode well for the global gene editing market.

Competition Outlook

Horizon Discovery Group plc, New England Biolabs, Inc., Sangamo Biosciences, Inc., Lonza Group Ltd., OriGene Technologies, Inc., Thermo Fisher Scientific, Inc., Transposagen Biopharmaceuticals, Inc., GenScript USA Inc., Integrated DNA Technologies, Inc., and Sigma-Aldrich Corporation are premier biotechnology companies in the global gene editing market. Sharing of technology, mergers and acquisitions, and partnerships are on the rise in the market. Recently, Horizon Discovery Group has decided to share a customized version of the CRISPR technology with its partners for the development of cell therapies.

Industry News

The Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG have decided to collaborate on introducing multiple edits of the DNA of single cells in CRISPR technology. This can drive forward the applications of cell lines in biopharmaceutical, pharmaceutical, and clinical sectors.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/gene-editing-market-707 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Veterinary POC Diagnostic Market-trends, demand, news, growth by 2027

 

Market Highlights

According to MRFR analysis, the Global Veterinary POC Diagnostic Market is expected to register a CAGR of 8.9% during the forecast period of 2020 to 2027 and reach USD 2,894 Million by 2027.

Changes in veterinary healthcare system like Point-of-Care (POC), it enables rapid results in non-laboratory settings. There is traction in the veterinary point-of-care diagnostics market due to the adoption of advanced and innovative diagnostic testing methods.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/10018

The growth of the global veterinary POC diagnostic market can be attributed to the growing need for rescue medication, demand for POC diagnostic in the field of veterinary as the diseases in animals is increasing and affecting the human being as well.

Furthermore, growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for pet insurance & growing animal health expenditure, an increasing number of veterinary practitioners, increase in income levels in developed economies are expected to fuel the market growth during the forecast period.

However, the increasing pet care costs and high cost of veterinary imaging instruments are expected to restrain the growth of the global veterinary POC diagnostic market.

Several market players such as IDEXX Laboratories, Heska Corporation, and Fujifilm among others currently dominate the global veterinary POC diagnostic market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions, for instance, In January 2020, IDEXX launched the Vcheck Feline NT-proBNP test kit, In January 2020, Heska Corporation acquired SCIL Animal Care Company (Germany) to complement the company's veterinary diagnostics portfolio and expand the geographic portfolio across North America and greater Europe and reach over to 25 countries across these regions., In July 2019, Fujifilm Corporation established FUJIFILM VET Systems Co., Ltd in Japan to supply its veterinary products segment to veterinary clinical practices in the country. This expansion would enhance the company's veterinary medicine business in Japan. In January 2018, IDEXX launched the IDEXX Catalyst SDMA Test.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/veterinary-poc-diagnostic-market-10018

Segmentation

Global Veterinary POC Diagnostic Market has been segmented based on the Product, Technology, Application, Animal Type, and End User.

Based on the type, the global veterinary POC diagnostic market has been segmented into Consumable, Instruments. The consumable segment is expected to hold the largest market share owing to the increasing demand for the rapid detection of diseases, the growing prevalence of animal zoonotic diseases.

On the basis of technology, the market has been segmented into Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, and Molecular Diagnostics. Clinical Biochemistry is expected to hold a major market share due to the higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

Based on the application, the market has been segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, Orthopedics & traumatology, Gynecology, Oncology, Cardiology, and Neurology. Clinical pathology is expected to grow at the fastest CAGR.

The market based on end user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Based on the animal type, the market has been segmented into Companion animals, Livestock Animals. Clinical pathology is expected to grow at the fastest CAGR.

Key Players

Thermo Fisher Scientific, Inc. (US), Idexx Laboratories, Inc. (US), Zoetis, Inc. (US), Virbac (France), Heska Corporation (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company Ltd. (UK), Randox Laboratories, Ltd. (UK), AniPoC, Ltd. (UK), Carestream Health, Inc. (US), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), GE Healthcare (US), Minxray, Inc. (US), QR s.r.l. (Italy), Sedecal (Spain), Examion GmbH (Germany)

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising animal zoonotic diseases in the region. The veterinary POC diagnostic market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European veterinary POC diagnostic market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The veterinary POC diagnostic market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing zoonotic diseases, the market in Asia-Pacific is expected to be the fastest-growing. The veterinary POC diagnostic market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

 

  

Global Demand on Neurology Devices Market Forecast to 2027

 

Market Highlights

According to MRFR analysis, the Global Neurology Devices Market is expected to register a CAGR of 10.2% during the forecast period of 2020 to 2027 and reach USD 21,029.7 Million by 2027.

Neurology devices are used for the treatment of neurological disorders that comprise pathophysiological conditions that affect the brain, spinal cord, and nervous system.

 

Get Free Sample @  https://www.marketresearchfuture.com/sample_request/9768

The market for neurology devices is expected to grow at boost due to a surge in the prevalence of the neurological disorder, a growing aging population, increasing adoption of technologically advanced devices, and growing demand for minimally invasive devices. However, high cost and stringent regulatory government regulations are some of the factors expected to hinder the growth of the market.

 

The global market is expected to witness a profitable growth owing to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors. As per the statistics of WHO in 2017, around 50 million people all over the world were affected by epilepsy. Additionally, Alzheimer's Research UK stated that over 50.8 million people worldwide were affected by dementia in 2017 and was expected to reach 55 million patients in 2020. Moreover, this number would double every 20 years, reaching 75 million by 2030 and 131.5 million by 2050. These huge prevalence of neurological disorders among the population and rising healthcare expenditure for neurological disorders are driving the growth of the neurology devices market.

 

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the increasing adoption of technological devices, favorable reimbursement scenarios, and the presence of major manufacturers among others. The neurology devices market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European neurology devices market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The neurology devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing geriatric population, the market in Asia-Pacific is expected to be the fastest-growing. The neurology devices market in the Middle East & Africa has been divided into the Middle East and Africa.

 

 

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/neurology-devices-market-9768 

 

 

Segmentation

 

The global neurology devices market has been segmented based on the product, and end user.

 

Based on product the market is segmented into neurostimulation, Interventional neurology, CSF management, and Neurosurgery devices. Neurostimulation segment accounted for the major market share owing to the increasing prevalence of epilepsy, Parkinson's disease, tremor, dystonia, depression, obsessive-compulsive disorder, Tourette syndrome, chronic pain, and cluster headache. The segment is further bifurcated by spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation, vagus nerve stimulation, and gastric electric stimulation.

 

Interventional neurology segment is divided into aneurysm coiling & embolization (embolic coils, flow diversion devices, liquid embolic agents), cerebral balloon angioplasty & stenting (carotid artery stents, filter devices, balloon occlusion devices), neurothrombectomy (clot retriever, suction aspiration devices, snares). Moreover, CSF management is further distributed into the following sub-segments, CSF shunts, and CSF drainage. The neurosurgery devices segment is further sub-segmented into ultrasonic aspirators, stereotactic systems, neuroendoscopes, and aneurysm clips. The segment is expected to grow at the fastest CAGR during the forecast period owing to the increasing demand for non-invasive neurosurgery.

 

The market based on end users has been segmented into hospitals & clinics, specialty centers, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

 

 

Key Players

 

Some of the key players in the global neurology devices market are B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic Inc., St. Jude Medical, Inc., Stryker Corporation, W.L. Gore & Associates, Inc., and Esaote, among others

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

 

Global Hemorrhoid Treatment Devices Market Overview, Growth Analysis, Drivers and Top Company Profiles

 

Market Highlights

Global Hemorrhoid Treatment Devices Market is expected to have a market value of USD 973.94 Million by2025. Hemorrhoids, also called piles, are swollen and inflamed blood vessels in the anus as well as in the lower rectum. The global hemorrhoid treatment devices market is expected to grow at a steady rate owing to the increasing incidence rate of hemorrhoid cases and increasing initiatives by the public as well as private companies operating in the market. For instance, the number of people suffering from hemorrhoids in the US is currently estimated to be around 10.4 million; in addition, about 1 million new cases of hemorrhoids occur each year. Also, symptomatic hemorrhoids affect at least 50% of the population at some time during their lives.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8726

Regional Analysis

The global hemorrhoid treatment devices market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas led the market and accounted for the largest share in 2018, owing to the presence of major market players, developed healthcare infrastructure, high awareness, and availability of advanced treatment options. Also, a favorable reimbursement scenario for hemorrhoid treatment surgeries is fueling the growth of this region in the hemorrhoid treatment devices market.

Europe accounts for the second-largest share in the global hemorrhoid treatment devices market. In 2018, 30% to 70% of adults were overweight in the European Union countries. Also, obesity affected 10% to 30% of adults in the European Union countries. Excess weight or pressure results in the constriction of veins and blood vessels surrounding the anus and colon. This increases the risk of developing hemorrhoids in obese individuals, thereby supporting the regional market growth.

Asia-Pacific is estimated to be the fastest-growing market during the forecast period due to the rising incidence of hemorrhoids and developing the healthcare sector in Asian countries, such as China, Japan, India, and Australia. Moreover, the increasing focus of big pharmaceutical companies to enter into this region is expected to drive the market growth.

The Middle East & Africa hemorrhoid treatment devices market is segmented into two major regions, namely the Middle East and Africa. The Middle East and Africa have fewer economic developments due to which the region accounts for the least market share but is expected to grow due to the growing demand for better treatments in these countries.

Access Report Details @ https://www.marketresearchfuture.com/reports/hemorrhoid-treatment-devices-market-8726

Segment Analysis

The global hemorrhoid treatment devices market has been segmented based on device type, procedure, and end-user. The market, based on device type, has been segmented into rubber band ligators, infrared coagulators, proctoscopes, anoscopes, doppler probes, cryotherapy devices, bipolar probes, and others. The market, based on procedure, has been categorized into rubber band ligation, sclerotherapy, infrared coagulation, and others. The market, based on end-user, has been divided into hospitals and clinics, ambulatory surgery centers, and others.

 

Key Players

MRFR recognizes the following companies as the Key Players in the Global Hemorrhoid Treatment Devices Market— Cook Medical (US), Medtronic plc (Ireland), Privi Medical (Singapore), Integra LifeSciences Corporation (Israel), Sklar Surgical Instruments (US), OBP Medical Corporation (US), CONMED Corporation (US), Boston Scientific Corporation (US), and Johnson & Johnson Services, Inc. (US).

Key Findings of the Study

The Global Hemorrhoid Treatment Devices Market is estimated to reach USD 973.94 Million by 2025 at a CAGR of 5.98% during the assessment period of 2019 to 2025.

The Americas accounted for the largest share of the global hemorrhoid treatment devices market due to the existence of medical device companies and the rising incidence rate of hemorrhoid cases, along with increased adoption of treatment by patients.

Based on the device type, the rubber band ligators segment accounted for the largest market share of 14% in 2018.

Based on the procedure, the rubber band ligation segment accounted for the largest market share of 39.2% in 2018.

On the basis of end-user, the hospitals and clinics segment accounted for the largest market share of 50.1% in 2018.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/